Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$27.79 -0.29 (-1.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Depreciation and Depletion (2021 - 2026)

Updated

Amylyx Pharmaceuticals' Depreciation and Depletion came in at $43,000 for Q2 2026, down 69.5% from $141,000 a year earlier and down 56.1% from the prior quarter.

Analysis

Amylyx Pharmaceuticals (AMLX) Depreciation and Depletion (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Amylyx Pharmaceuticals reported Depreciation and Depletion of $369,000, down 45.6% year-over-year; for FY2025, it was $525,000, down 41.9% from FY2024.

  • Depreciation and Depletion carries a four-year compound annual growth rate of 78.3% (FY2021 to FY2025).
  • Going back by year, Depreciation and Depletion was $904,000 in FY2024 (-16.9%), $1.09 million in FY2023 (+123.4%), $487,000 in FY2022 (+836.5%) and $52,000 in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Depreciation and Depletion since Q1 2022.
  • Year-over-year, Depreciation and Depletion has declined for nine consecutive quarters, with an average decline of 42.7% over the last eight quarters.
  • The fastest year-over-year change in Depreciation and Depletion over five years came in Q2 2022 (growth of 950.0%), and the weakest in Q2 2026 (a decline of 69.5%).
  • Business Quant data shows AMLX's Depreciation and Depletion at $98,000 (Q1 2026), $108,000 (Q4 2025) and $120,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Amylyx Pharmaceuticals 3.13 Bn 3.13 Bn - 43,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43,000.00
Mar 31, 2026 98,000.00
Dec 31, 2025 108,000.00
Sep 30, 2025 120,000.00
Jun 30, 2025 141,000.00
Mar 31, 2025 156,000.00
Dec 31, 2024 160,000.00
Sep 30, 2024 221,000.00
Jun 30, 2024 208,000.00
Mar 31, 2024 315,000.00
Dec 31, 2023 301,000.00
Sep 30, 2023 302,000.00
Jun 30, 2023 281,000.00
Mar 31, 2023 204,000.00
Dec 31, 2022 182,000.00
Sep 30, 2022 165,000.00
Jun 30, 2022 105,000.00
Mar 31, 2022 35,000.00
Dec 31, 2021 22,000.00
Sep 30, 2021 10,000.00
API Access

Amylyx Pharmaceuticals Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=AMLX&period=max&api_key=YOUR_API_KEY